Cortisol and cytokines in schizophrenia: A scoping review
Background: With a complex etiology and chronic, disabling evolution, schizophrenia continues to represent a challenge for patients, clinicians, and researchers alike. Recent emphasis in research on finding practical blood-based biomarkers for diagnosis improvement, disease development prediction, a...
Main Authors: | Adriana Farcas, Praise Christi, Felicia Iftene |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Comprehensive Psychoneuroendocrinology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666497623000267 |
Similar Items
-
Is befriending a valuable intervention in schizophrenia? A scoping review
by: Adriana Farcas, et al.
Published: (2023-06-01) -
BDNF changes as a result of non-pharmacological interventions in schizophrenia – A scoping review
by: Adriana Farcas, et al.
Published: (2023-06-01) -
Salivary cortisol in Schizophrenia: a selective review and meta-analysis of controlled studies of the past decade
by: Walter Paganin, et al.
Published: (2024-12-01) -
HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation
by: Joanna Mikulska, et al.
Published: (2021-09-01) -
The relationship between psychopathology and cognitive functions with cytokines in clinically stable patients with schizophrenia
by: Serhat Ergün, et al.
Published: (2018-01-01)